TMCI
Treace Medical Concepts Stock Analysis
AI Rating
- Quality1/10
- Growth↑ 6/10
- Momentum↓ 0/10
TMCI Growth
- Revenue Y/Y↑ 7.90%
- EPS Y/Y↑ 19.19%
- FCF Y/Y↑ 39.01%
TMCI Profitability
- Gross margin ↑ 79.90%
- EPS margin↓ -22.90%
- ROIC↓ -21.80%
TMCI Risk
- Debt / Equity↓ 0.7
- Debt / FCF↓ 2.2
- Interest coverage↓ -8.5
Treace Medical Concepts stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.